메뉴 건너뛰기




Volumn 14, Issue 9, 2016, Pages 1711-1714

Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BIOLOGICAL MARKER; NONSTEROID ANTIINFLAMMATORY AGENT; WARFARIN;

EID: 84988529625     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13386     Document Type: Note
Times cited : (101)

References (20)
  • 1
    • 84943138698 scopus 로고    scopus 로고
    • Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy
    • Lip GY, Skjoth F, Nielsen PB, Larsen TB. Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy. Thromb Haemost 2015; 114: 826–34.
    • (2015) Thromb Haemost , vol.114 , pp. 826-834
    • Lip, G.Y.1    Skjoth, F.2    Nielsen, P.B.3    Larsen, T.B.4
  • 3
    • 84893179904 scopus 로고    scopus 로고
    • Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate
    • Majeed A, Meijer K, Larrazabal R, Arnberg F, Luijckx GJ, Roberts RS, Schulman S. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate. Thromb Haemost 2014; 111: 233–9.
    • (2014) Thromb Haemost , vol.111 , pp. 233-239
    • Majeed, A.1    Meijer, K.2    Larrazabal, R.3    Arnberg, F.4    Luijckx, G.J.5    Roberts, R.S.6    Schulman, S.7
  • 4
    • 34547693119 scopus 로고    scopus 로고
    • Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
    • Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E; BAFTA Investigators; Midland Research Practices Network. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493–503.
    • (2007) Lancet , vol.370 , pp. 493-503
    • Mant, J.1    Hobbs, F.D.2    Fletcher, K.3    Roalfe, A.4    Fitzmaurice, D.5    Lip, G.Y.6    Murray, E.7
  • 5
    • 84908543945 scopus 로고    scopus 로고
    • Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials
    • Vanassche T, Hirsh J, Eikelboom JW, Ginsberg JS. Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials. Thromb Haemost 2014; 112: 918–23.
    • (2014) Thromb Haemost , vol.112 , pp. 918-923
    • Vanassche, T.1    Hirsh, J.2    Eikelboom, J.W.3    Ginsberg, J.S.4
  • 6
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey
    • Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093–100.
    • (2010) Chest , vol.138 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3    de Vos, C.B.4    Crijns, H.J.5    Lip, G.Y.6
  • 7
    • 84889818750 scopus 로고    scopus 로고
    • The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation
    • Roldan V, Marin F, Manzano-Fernandez S, Gallego P, Vilchez JA, Valdes M, Vicente V, Lip GY. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2013; 62: 2199–204.
    • (2013) J Am Coll Cardiol , vol.62 , pp. 2199-2204
    • Roldan, V.1    Marin, F.2    Manzano-Fernandez, S.3    Gallego, P.4    Vilchez, J.A.5    Valdes, M.6    Vicente, V.7    Lip, G.Y.8
  • 8
    • 84951170841 scopus 로고    scopus 로고
    • Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors
    • Lip GY, Lane DA. Assessing bleeding risk in atrial fibrillation with the HAS-BLED and ORBIT scores: clinical application requires focus on the reversible bleeding risk factors. Eur Heart J 2015; 36: 3265–7.
    • (2015) Eur Heart J , vol.36 , pp. 3265-3267
    • Lip, G.Y.1    Lane, D.A.2
  • 9
    • 80052094564 scopus 로고    scopus 로고
    • A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    • Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011; 58: 395–401.
    • (2011) J Am Coll Cardiol , vol.58 , pp. 395-401
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3    Borowsky, L.H.4    Pomernacki, N.K.5    Udaltsova, N.6    Singer, D.E.7
  • 13
    • 82655172003 scopus 로고    scopus 로고
    • Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association (EHRA), endorsed by the European Society of Cardiology (ESC) Working Group on Thrombosis
    • Lip GY, Andreotti F, Fauchier L, Huber K, Hylek E, Knight E, Lane D, Levi M, Marin F, Palareti G, Kirchhof P. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association (EHRA), endorsed by the European Society of Cardiology (ESC) Working Group on Thrombosis. Thromb Haemost 2011; 106: 997–1011.
    • (2011) Thromb Haemost , vol.106 , pp. 997-1011
    • Lip, G.Y.1    Andreotti, F.2    Fauchier, L.3    Huber, K.4    Hylek, E.5    Knight, E.6    Lane, D.7    Levi, M.8    Marin, F.9    Palareti, G.10    Kirchhof, P.11
  • 14
    • 33748360506 scopus 로고    scopus 로고
    • Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation
    • Lip GY, Lane D, van Walraven C, Hart RG. Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. Stroke 2006; 37: 2294–300.
    • (2006) Stroke , vol.37 , pp. 2294-2300
    • Lip, G.Y.1    Lane, D.2    van Walraven, C.3    Hart, R.G.4
  • 16
    • 84963800755 scopus 로고    scopus 로고
    • Major bleeding in patients with non-valvular atrial fibrillation: impact of time in therapeutic range on contemporary bleeding risk scores
    • Proietti M, Senoo K, Lane DA, Lip GY. Major bleeding in patients with non-valvular atrial fibrillation: impact of time in therapeutic range on contemporary bleeding risk scores. Sci Rep 2016; 6: 24376.
    • (2016) Sci Rep , vol.6 , pp. 24376
    • Proietti, M.1    Senoo, K.2    Lane, D.A.3    Lip, G.Y.4
  • 17
    • 84960194211 scopus 로고    scopus 로고
    • Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in atrial fibrillation patients on warfarin
    • Senoo K, Proietti M, Lane DA, Lip GY. Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in atrial fibrillation patients on warfarin. Am J Med 2016; 129: 600–7.
    • (2016) Am J Med , vol.129 , pp. 600-607
    • Senoo, K.1    Proietti, M.2    Lane, D.A.3    Lip, G.Y.4
  • 18
    • 84861231518 scopus 로고    scopus 로고
    • Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study
    • Friberg L, Rosenqvist M, Lip GY. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 2012; 125: 2298–307.
    • (2012) Circulation , vol.125 , pp. 2298-2307
    • Friberg, L.1    Rosenqvist, M.2    Lip, G.Y.3
  • 19
    • 84897045662 scopus 로고    scopus 로고
    • Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation
    • Lahaye S, Regpala S, Lacombe S, Sharma M, Gibbens S, Ball D, Francis K. Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation. Thromb Haemost 2014; 111: 465–73.
    • (2014) Thromb Haemost , vol.111 , pp. 465-473
    • Lahaye, S.1    Regpala, S.2    Lacombe, S.3    Sharma, M.4    Gibbens, S.5    Ball, D.6    Francis, K.7
  • 20
    • 84897075930 scopus 로고    scopus 로고
    • Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation
    • Lane DA, Lip GY. Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation. Thromb Haemost 2014; 111: 381–3.
    • (2014) Thromb Haemost , vol.111 , pp. 381-383
    • Lane, D.A.1    Lip, G.Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.